Glucose-Regulated Protein 78 (GRP78) Mediated the Efficacy to Curcumin Treatment on Hepatocellular Carcinoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucose-Regulated Protein 78 (GRP78) Mediated the Efficacy to Curcumin Treatment on Hepatocellular Carcinoma
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 18, Issue 8, Pages 2395-2403
Publisher
Springer Nature
Online
2011-02-23
DOI
10.1245/s10434-011-1597-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma
- (2010) Yu-Jia Chang et al. ANNALS OF SURGICAL ONCOLOGY
- Knockdown of Thrombomodulin Enhances HCC Cell Migration through Increase of ZEB1 and Decrease of E-cadherin Gene Expression
- (2010) Ming-Te Huang et al. ANNALS OF SURGICAL ONCOLOGY
- Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials
- (2010) Tao Zhang et al. ANTI-CANCER DRUGS
- Review article: the management of hepatocellular carcinoma
- (2009) R. CABRERA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma
- (2009) Jeng-Fong Chiou et al. ANNALS OF SURGICAL ONCOLOGY
- Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design
- (2009) Chiun Hsu et al. Contemporary Clinical Trials
- Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial
- (2009) Lorenza Rimassa et al. Expert Review of Anticancer Therapy
- Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety
- (2009) Alessandro Vitale et al. HEPATOLOGY
- Curcumin and cancer: An “old-age” disease with an “age-old” solution
- (2008) Preetha Anand et al. CANCER LETTERS
- Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
- (2008) Ajaikumar B. Kunnumakkara et al. CANCER LETTERS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission
- (2008) Stefanie Sowinski et al. NATURE CELL BIOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN
- (2008) S.-K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
- (2008) Bharat B. Aggarwal et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started